Telomerase mutations in smokers with severe emphysema
Open accessThe DOI matches its Crossref record; 40 of the 42 references it cites were found in a registry or an index.
Abstract
Mutations in the essential telomerase genes TERT and TR cause familial pulmonary fibrosis; however, in telomerase-null mice, short telomeres predispose to emphysema after chronic cigarette smoke exposure. Here, we tested whether telomerase mutations are a risk factor for human emphysema by examining their frequency in smokers with chronic obstructive pulmonary disease (COPD). Across two independent cohorts, we found 3 of 292 severe COPD cases carried deleterious mutations in TERT (1%). This prevalence is comparable to the frequency of alpha-1 antitrypsin deficiency documented in this population. The TERT mutations compromised telomerase catalytic activity, and mutation carriers had short telomeres. Telomerase mutation carriers with emphysema were predominantly female and had an increased incidence of pneumothorax. In families, emphysema showed an autosomal dominant inheritance pattern, along with pulmonary fibrosis and other telomere syndrome features, but manifested only in smokers. Our findings identify germline mutations in telomerase as a Mendelian risk factor for COPD susceptibility that clusters in autosomal dominant families with telomere-mediated disease including pulmonary fibrosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Telomerase mutations are a risk factor for emphysema among patients with COPD68.”
From Telomere dysfunction in ageing and age-related diseases (2022) · cites this paper as [68]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A map of human genome variation from population-scale sequencing.
The 1000 Genomes Project Consortium (2010) · Nature · doi:10.1038/nature09534 · Cited by 7,877
Telomeres shorten during ageing of human fibroblasts
Harley, C. B., Futcher, A. B., & Greider, C. W. (1990) · Nature · doi:10.1038/345458a0 · Cited by 5,750 · cited 1×
“Telomeres shorten with cell division and advancing age, and short dysfunctional telomeres signal a DNA damage response that provokes cellular senescence and apoptosis (5, 6).”
BackgroundIdentification of a specific telomere terminal transferase activity in tetrahymena extracts
Greider, C. W., & Blackburn, E. H. (1985) · Cell · doi:10.1016/0092-8674(85)90170-9 · Cited by 3,400 · cited 1×
“Telomerase is the specialized polymerase that synthesizes new telomere repeats (7–9).”
BackgroundA telomeric sequence in the RNA of Tetrahymena telomerase required for telomere repeat synthesis
Greider, C. W., & Blackburn, E. H. (1989) · Nature · doi:10.1038/337331a0 · Cited by 1,643 · cited 2×
“It has two core components: TERT, the telomerase reverse transcriptase, and TR, the telomerase RNA that provides the template for telomere repeat addition (9, 10).”
BackgroundTelomere length measurement by a novel monochrome multiplex quantitative PCR method
Cawthon, R. M. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkn1027 · Cited by 1,410
Telomerase Mutations in Families with Idiopathic Pulmonary Fibrosis
Armanios, M. Y., Chen, J. J.-L., Cogan, J. D., Alder, J. K., Ingersoll, R. G., Markin, C., Lawson, W. E., Xie, M., Vulto, I., Phillips, J. A., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066157 · Cited by 1,357
Self-citationAnthonisen, N. R. (1994) · JAMA · doi:10.1001/jama.1994.03520190043033 · Cited by 1,341 · cited 2×
“n = 415) were smokers who were selected for extreme phenotypes (33).”
BackgroundMethodGenetic epidemiology of copd (copdgene) study design
Regan, E. A., Hokanson, J. E., Murphy, J. R., Make, B., Lynch, D. A., Beaty, T. H., Curran-Everett, D., Silverman, E. K., & Crapo, J. D. (2011) · COPD: Journal of Chronic Obstructive Pulmonary Disease · doi:10.3109/15412550903499522 · Cited by 1,313
Self-citationComorbidities and Risk of Mortality in Patients with Chronic Obstructive Pulmonary Disease
Divo, M., Cote, C., de Torres, J. P., Casanova, C., Marin, J. M., Pinto-Plata, V., Zulueta, J., Cabrera, C., Zagaceta, J., Hunninghake, G., et al. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201201-0034oc · Cited by 1,275
Reverse Transcriptase Motifs in the Catalytic Subunit of Telomerase
Lingner, J., Hughes, T. R., Shevchenko, A., Mann, M., Lundblad, V., & Cech, T. R. (1997) · Science · doi:10.1126/science.276.5312.561 · Cited by 1,269 · cited 1×
“It has two core components: TERT, the telomerase reverse transcriptase, and TR, the telomerase RNA that provides the template for telomere repeat addition (9, 10).”
Background
Research works printed but not linked: 2
- Kochanek, 2011, Natl Vital Stat Rep., 60, 1
- Liang, 2006, Haematologica., 91, 656
Cited by
Blackburn, E. H., Epel, E. S., & Lin, J. (2015) · Science · doi:10.1126/science.aab3389 · Cited by 1,596
Telomere dysfunction in ageing and age-related diseases
Rossiello, F., Jurk, D., Passos, J. F., & d’Adda di Fagagna, F. (2022) · Nature Cell Biology · doi:10.1038/s41556-022-00842-x · Cited by 754
Towards the elimination of chronic obstructive pulmonary disease: a Lancet Commission
Stolz, D., Mkorombindo, T., Schumann, D. M., Agusti, A., Ash, S. Y., Bafadhel, M., Bai, C., Chalmers, J. D., Criner, G. J., Dharmage, S. C., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(22)01273-9 · Cited by 681
Self-citationUpdate on the Pathogenesis of Chronic Obstructive Pulmonary Disease
Agustí, A., & Hogg, J. C. (2019) · New England Journal of Medicine · doi:10.1056/nejmra1900475 · Cited by 551
The aging lung: Physiology, disease, and immunity
Schneider, J. L., Rowe, J. H., Garcia-de-Alba, C., Kim, C. F., Sharpe, A. H., & Haigis, M. C. (2021) · Cell · doi:10.1016/j.cell.2021.03.005 · Cited by 500
“Harboring this genotype results in compromised catalytic activity of telomerase and shortened telomeres, demonstrating that germline mutations in telomere regulatory genes are a risk factor for COPD susceptibility (Stanley et al., 2015).”
Cai, Y., Song, W., Li, J., Jing, Y., Liang, C., Zhang, L., Zhang, X., Zhang, W., Liu, B., An, Y., et al. (2022) · Science China Life Sciences · doi:10.1007/s11427-022-2161-3 · Cited by 408
Lung Cancers: Molecular Characterization, Clonal Heterogeneity and Evolution, and Cancer Stem Cells
Testa, U., Castelli, G., & Pelosi, E. (2018) · Cancers · doi:10.3390/cancers10080248 · Cited by 403
“In fact, recent studies have shown that mutations in telomerase (TERT and TR) represent the most commonly observed risk factor predisposing to the development of idiopathic pulmonary fibrosis; furthermore, telomerase mutations predispose to emphysema development in smoker patients, as well as alpha-1 antitrypsin defic…”
BackgroundTelomere-related lung fibrosis is diagnostically heterogeneous but uniformly progressive
Newton, C. A., Batra, K., Torrealba, J., Kozlitina, J., Glazer, C. S., Aravena, C., Meyer, K., Raghu, G., Collard, H. R., & Garcia, C. K. (2016) · European Respiratory Journal · doi:10.1183/13993003.00308-2016 · Cited by 400
“And the radiographic emphysema phenotype was not only significantly associated with smoking and the TERT mutation group as has been recently described [28], but also associated with the RTEL1 gene.”
BackgroundCOPDGene Investigators, Hobbs, B. D., ECLIPSE Investigators, LifeLines Investigators, SPIROMICS Research Group, International COPD Genetics Network Investigators, UK BiLEVE Investigators, International COPD Genetics Consortium, de Jong, K., Lamontagne, M., et al. (2017) · Nature Genetics · doi:10.1038/ng.3752 · Cited by 398
Self-citationSakornsakolpat, P., Prokopenko, D., Lamontagne, M., Reeve, N. F., Guyatt, A. L., Jackson, V. E., Shrine, N., Qiao, D., Bartz, T. M., Kim, D. K., et al. (2019) · Nature Genetics · doi:10.1038/s41588-018-0342-2 · Cited by 384
“…telomere maintenance 103 ; shortened telomeres have been observed in both COPD and idiopathic pulmonary fibrosis (IPF) 104,105 , and rare genetic variants in the telomerase pathway have been implicated in both pulmonary fibrosis and emphysema – albeit with concordant effects on either disease 106 .”
Self-citationTelomere dysfunction causes alveolar stem cell failure
Alder, J. K., Barkauskas, C. E., Limjunyawong, N., Stanley, S. E., Kembou, F., Tuder, R. M., Hogan, B. L. M., Mitzner, W., & Armanios, M. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1504780112 · Cited by 339
“Idiopathic pulmonary fibrosis and emphysema are the most prevalent clinical manifestations of human telomere syndromes and account for more than 80% of presentations (1, 2).”
BackgroundSelf-citationInflammatory endotypes in COPD
Barnes, P. J. (2019) · Allergy · doi:10.1111/all.13760 · Cited by 313
Diagnostic utility of telomere length testing in a hospital-based setting
Alder, J. K., Hanumanthu, V. S., Strong, M. A., DeZern, A. E., Stanley, S. E., Takemoto, C. M., Danilova, L., Applegate, C. D., Bolton, S. G., Mohr, D. W., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1720427115 · Cited by 268
“The age at diagnosis and telomere phenotype were extracted from the medical record, as previously described (11, 12, 18).”
BackgroundMethodInfluentialSelf-citationSenescence in COPD and Its Comorbidities
Barnes, P. J. (2017) · Annual Review of Physiology · doi:10.1146/annurev-physiol-022516-034314 · Cited by 266
Mice with Pulmonary Fibrosis Driven by Telomere Dysfunction
Povedano, J. M., Martinez, P., Flores, J. M., Mulero, F., & Blasco, M. A. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.06.028 · Cited by 225
“More recently, telomerase mutations leading to abnormally short telomeres have also been found in up to 1% of smokers with chronic obstructive pulmonary disease (COPD) (Stanley et al., 2015).”
BackgroundInfluentialCottin, V., Selman, M., Inoue, Y., Wong, A. W., Corte, T. J., Flaherty, K. R., Han, M. K., Jacob, J., Johannson, K. A., Kitaichi, M., et al. (2022) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202206-1041st · Cited by 226
mTOR pathway activation drives lung cell senescence and emphysema
Houssaini, A., Breau, M., Kebe, K., Abid, S., Marcos, E., Lipskaia, L., Rideau, D., Parpaleix, A., Huang, J., Amsellem, V., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.93203 · Cited by 220
“That cell senescence may lead to lung emphysema is also strongly indicated by the occurrence of severe lung emphysema in some patients with telomere gene mutations (50).”
Silverman, E. K. (2020) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021317-121224 · Cited by 211
Self-citationStanley, S. E., Gable, D. L., Wagner, C. L., Carlile, T. M., Hanumanthu, V. S., Podlevsky, J. D., Khalil, S. E., DeZern, A. E., Rojas-Duran, M. F., Applegate, C. D., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf7837 · Cited by 210
Self-citationBrandsma, C., Van den Berge, M., Hackett, T., Brusselle, G., & Timens, W. (2020) · The Journal of Pathology · doi:10.1002/path.5364 · Cited by 204
“Furthermore, mutations in genes responsible for telomere shortening, a hallmark of aging, have been associated with severe emphysema [61,62].”
BackgroundPrevalence and characteristics of TERT and TERC mutations in suspected genetic pulmonary fibrosis
Borie, R., Tabèze, L., Thabut, G., Nunes, H., Cottin, V., Marchand-Adam, S., Prevot, G., Tazi, A., Cadranel, J., Mal, H., et al. (2016) · European Respiratory Journal · doi:10.1183/13993003.02115-2015 · Cited by 184
Exome Sequencing Identifies Mutant TINF2 in a Family With Pulmonary Fibrosis
Alder, J. K., Stanley, S. E., Wagner, C. L., Hamilton, M., Hanumanthu, V. S., & Armanios, M. (2015) · Chest · doi:10.1378/chest.14-1947 · Cited by 181
Self-citationNoncanonical WNT-5A signaling impairs endogenous lung repair in COPD
Baarsma, H. A., Skronska-Wasek, W., Mutze, K., Ciolek, F., Wagner, D. E., John-Schuster, G., Heinzelmann, K., Günther, A., Bracke, K. R., Dagouassat, M., et al. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20160675 · Cited by 178
“Moreover, WNT-5A can suppress telomerase activity, and impaired telomerase activity increases the susceptibility to develop COPD/emphysema (Olson et al., 1998; Stanley et al., 2015).”
BackgroundMitochondria, telomeres and cell senescence: Implications for lung ageing and disease
Birch, J., Barnes, P. J., & Passos, J. F. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.10.005 · Cited by 170
“Similarly, deleterious mutations in hTERT have been found in cohorts of patients with severe COPD and have been identified as a risk factor for emphysema susceptibility in smokers, showing an autosomal dominant inheritance pattern in families (Stanley et al., 2015).”
BackgroundHecker, L. (2018) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00275.2017 · Cited by 153
“Genetic defects in telomerase and telomere genes have been associated with COPD (114).”
BackgroundLong telomeres and cancer risk: the price of cellular immortality
McNally, E. J., Luncsford, P. J., & Armanios, M. Y. (2019) · Journal of Clinical Investigation · doi:10.1172/jci120851 · Cited by 167
“These telomere-related lung disorders in the vast majority show autosomal dominant inheritance and may appear as emphysema in smokers (45, 46).”
BackgroundSelf-citationPovedano, J. M., Martinez, P., Serrano, R., Tejera, Á., Gómez-López, G., Bobadilla, M., Flores, J. M., Bosch, F., & Blasco, M. A. (2018) · eLife · doi:10.7554/elife.31299 · Cited by 139
The Telomere/Telomerase System in Chronic Inflammatory Diseases. Cause or Effect?
Kordinas, V., Ioannidis, A., & Chatzipanagiotou, S. (2016) · Genes · doi:10.3390/genes7090060 · Cited by 140
“On the other hand, smoking is associated with higher telomerase activity in vitro, while certain telomerase mutations have been discovered that cause severe emphysema in carriers that smoke [79,91].”
BackgroundCancer spectrum and outcomes in the Mendelian short telomere syndromes
Schratz, K. E., Haley, L., Danoff, S. K., Blackford, A. L., DeZern, A. E., Gocke, C. D., Duffield, A. S., & Armanios, M. (2020) · Blood · doi:10.1182/blood.2019003264 · Cited by 132
Self-citationCho, M. H., Hobbs, B. D., & Silverman, E. K. (2022) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(21)00510-5 · Cited by 184
Self-citationTelomere-mediated lung disease
Alder, J. K., & Armanios, M. (2022) · Physiological Reviews · doi:10.1152/physrev.00046.2021 · Cited by 130
Self-citationHepatopulmonary Syndrome Is a Frequent Cause of Dyspnea in the Short Telomere Disorders
Gorgy, A. I., Jonassaint, N. L., Stanley, S. E., Koteish, A. A., Dezern, A. E., Walter, J. E., Sopha, S. C., Hamilton, J. P., Hoover-Fong, J. E., Chen, A. R., et al. (2015) · CHEST Journal · doi:10.1378/chest.15-0825 · Cited by 133
Self-citationEuropean Respiratory Society statement on familial pulmonary fibrosis
Borie, R., Kannengiesser, C., Antoniou, K. M., Bonella, F., Crestani, B., Fabre, A., Froidure, A., Galvin, L., Griese, M., Grutters, J. C., et al. (2022) · European Respiratory Journal · doi:10.1183/13993003.01383-2022 · Cited by 147
The Role of Telomeres in Human Disease
Armanios, M. (2022) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-010422-091101 · Cited by 126
“The latter observations have highlighted a nuanced model where a gene–environment interaction (short telomeres and cigarette smoke) determines the predominant pulmonary phenotype (emphysema versus fibrosis), but this interaction is influenced by sex differences (5, 88, 90).”
BackgroundSelf-citationShort telomere syndromes cause a primary T cell immunodeficiency
Wagner, C. L., Hanumanthu, V. S., Talbot, C. C., Abraham, R. S., Hamm, D., Gable, D. L., Kanakry, C. G., Applegate, C. D., Siliciano, J., Jackson, J. B., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci120216 · Cited by 124
“Sanger verification (45), or exome and genome sequencing (46–48).”
Self-citationThe short and long telomere syndromes: paired paradigms for molecular medicine
Stanley, S. E., & Armanios, M. (2015) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2015.06.004 · Cited by 124
Self-citationGable, D. L., Gaysinskaya, V., Atik, C. C., Talbot, C. C., Kang, B., Stanley, S. E., Pugh, E. W., Amat-Codina, N., Schenk, K. M., Arcasoy, M. O., et al. (2019) · Genes & Development · doi:10.1101/gad.326785.119 · Cited by 121
“To screen forZCCHC8mutations in short telomere syndrome patients, we sequenced gDNA for the coding sequence and exon–intron junctions on a customized targeted nextgen sequencing panel (Truseq, Illumina) as shown previously (n = 21 cases) (Stanley et al. 2015).”
MethodSelf-citationMulugeta, S., Nureki, S.-I., & Beers, M. F. (2015) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00139.2015 · Cited by 118
Popescu, I., Mannem, H. C., Winters, S. A., Hoji, A., Silveira, F. P., McNally, E. J., Pipeling, M. R., Lendermon, E. A., Morrell, M. R., Pilewski, J. M., et al. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201805-0825oc · Cited by 119
Self-citationTERT gene: its function and dysregulation in cancer
Colebatch, A. J., Dobrovic, A., & Cooper, W. A. (2019) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2018-205653 · Cited by 116
Short Telomere Syndromes in Clinical Practice: Bridging Bench and Bedside
Mangaonkar, A. A., & Patnaik, M. M. (2018) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2018.03.020 · Cited by 98
Genetic Advances in Chronic Obstructive Pulmonary Disease. Insights from COPDGene
Ragland, M. F., Benway, C. J., Lutz, S. M., Bowler, R. P., Hecker, J., Hokanson, J. E., Crapo, J. D., Castaldi, P. J., DeMeo, D. L., Hersh, C. P., et al. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201808-1455so · Cited by 116
Self-citationPathogenesis, clinical features of asthma COPD overlap, and therapeutic modalities
Dey, S., Eapen, M. S., Chia, C., Gaikwad, A. V., Wark, P. A. B., & Sohal, S. S. (2021) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00121.2021 · Cited by 114
Chen, R., Zhang, K., Chen, H., Zhao, X., Wang, J., Li, L., Cong, Y., Ju, Z., Xu, D., Williams, B. R. G., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.681619 · Cited by 89
“Loss-of-function gene mutations on telomerase subunits occur in a number of diseases (3, 4), including dyskeratosis congenita (5, 6), aplastic anemia (7, 8), liver cirrhosis (9, 10), and idiopathic pulmonary fibrosis (IPF)2 (11– 14).”
BackgroundInfluentialBoone, P. M., Scott, R. M., Marciniak, S. J., Henske, E. P., & Raby, B. A. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201807-1212ci · Cited by 106
“These include: Sotos syndrome (148), spinocerebellar ataxia type 1 (149), telomerase reverse transcriptase (TERT gene) mutations (emphysema and pneumothorax in smokers) (150), hereditary mucoepithelial dysplasia (151), and diffuse dendriform pulmonary ossification (152).”
BackgroundCellular Senescence: The Trojan Horse in Chronic Lung Diseases
Hamsanathan, S., Alder, J. K., Sellares, J., Rojas, M., Gurkar, A. U., & Mora, A. L. (2019) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2018-0410tr · Cited by 86
Self-citationManagement of suspected monogenic lung fibrosis in a specialised centre
Borie, R., Kannengiesser, C., de Fontbrune, F. S., Gouya, L., Nathan, N., & Crestani, B. (2017) · European Respiratory Review · doi:10.1183/16000617.0122-2016 · Cited by 88
Schratz, K. E., Gaysinskaya, V., Cosner, Z. L., DeBoy, E. A., Xiang, Z., Kasch-Semenza, L., Florea, L., Shah, P. D., & Armanios, M. (2021) · Journal of Clinical Investigation · doi:10.1172/jci147598 · Cited by 77
Self-citationPulmonary fibrosis in the era of stratified medicine
Mathai, S. K., Newton, C. A., Schwartz, D. A., & Garcia, C. K. (2016) · Thorax · doi:10.1136/thoraxjnl-2016-209172 · Cited by 77
Link between increased cellular senescence and extracellular matrix changes in COPD
Woldhuis, R. R., de Vries, M., Timens, W., van den Berge, M., Demaria, M., Oliver, B. G. G., Heijink, I. H., & Brandsma, C. (2020) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00028.2020 · Cited by 84
Toward precision medicine in COPD: phenotypes, endotypes, biomarkers, and treatable traits
Xie, C. H., Wang, K., Yang, K., Zhong, Y., Gul, A., Luo, W., Yalikun, M., He, J., Chen, W., Xu, W., et al. (2025) · Respiratory Research · doi:10.1186/s12931-025-03356-w · Cited by 84
“Another genetic endotype involves telomerase gene (TERT) mutations or telomere biology disorders, which cause premature cellular senescence in the lungs and emphysema at a young age [103].”
Telomere Dysfunction and Cell Senescence in Chronic Lung Diseases: Therapeutic Potential
Adnot, S., Amsellem, V., Boyer, L., Marcos, É., Saker, M., Houssaini, A., Kebe, K., Dagouassat, M., Lipskaia, L., & Boczkowski, J. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.06.007 · Cited by 72
Genetic predisposition to leukemia and other hematologic malignancies
Feurstein, S. K., Drazer, M. W., & Godley, L. A. (2016) · Seminars in Oncology · doi:10.1053/j.seminoncol.2016.10.003 · Cited by 68
“Female smokers often experience emphysema instead of pulmonary fibrosis [25,26].”
BackgroundThe Intersection of Aging Biology and the Pathobiology of Lung Diseases: A Joint NHLBI/NIA Workshop
Budinger, G. S., Kohanski, R. A., Gan, W., Kobor, M. S., Amaral, L. A., Armanios, M., Kelsey, K. T., Pardo, A., Tuder, R., Macian, F., et al. (2017) · The Journals of Gerontology: Series A · doi:10.1093/gerona/glx090 · Cited by 68
“Genetic defects in telomerase and telomere genes markedly increase the risk of IPF and is in fact the most commonly identifiable cause of familial pulmonary fibrosis accounting for at least one-third of cases, and is a constitutional finding in at least half of IPF patients (73).”
BackgroundSelf-citationPulmonary phenotypes associated with genetic variation in telomere-related genes
Hoffman, T. W., van Moorsel, C. H. M., Borie, R., & Crestani, B. (2018) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000475 · Cited by 70
Borie, R., Bouvry, D., Cottin, V., Gauvain, C., Cazes, A., Debray, M., Cadranel, J. L., Dieudé, P., Dégot, T., Dominique, S., et al. (2018) · European Respiratory Journal · doi:10.1183/13993003.00508-2018 · Cited by 76
Aging and Lung Disease. Clinical Impact and Cellular and Molecular Pathways
Rojas, M., Mora, A. L., Kapetanaki, M., Weathington, N., Gladwin, M., & Eickelberg, O. (2015) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201508-484pl · Cited by 64
Sirtuin 1 and Aging Theory for Chronic Obstructive Pulmonary Disease
Conti, V., Corbi, G., Manzo, V., Pelaia, G., Filippelli, A., & Vatrella, A. (2015) · Analytical Cellular Pathology · doi:10.1155/2015/897327 · Cited by 70
“[50] reported that germline mutations in telomerase are a risk factor for severe emphysema in smokers by the evidence, in two independent humans cohorts, that 1% of cases carried deleterious mutations in TERT.”
Telomerase treatment prevents lung profibrotic pathologies associated with physiological aging
Piñeiro-Hermida, S., Autilio, C., Martínez, P., Bosch, F., Pérez-Gil, J., & Blasco, M. A. (2020) · Journal of Cell Biology · doi:10.1083/jcb.202002120 · Cited by 60
Ageing mechanisms that contribute to tissue remodeling in lung disease
Schuliga, M. J., Read, J. M., & Knight, D. A. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101405 · Cited by 65
Stanley, S. E., Merck, S. J., & Armanios, M. Y. (2016) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201609-718aw · Cited by 58
Self-citationThe aging lung: tissue telomere shortening in health and disease
Everaerts, S., Lammertyn, E. J., Martens, D. S., Sadeleer, L. D., Maes, K., van Batenburg, A. A., Goldschmeding, R., van Moorsel, C. H. M., Dupont, L., Wuyts, W. A., et al. (2018) · Respiratory Research · doi:10.1186/s12931-018-0794-z · Cited by 57
“Previous studies reported shorter peripheral blood LTL in COPD [11, 31, 32] and telomerase mutations have been demonstrated in 1% of COPD patients, which was associated with emphysema in families with autosomal dominant telomeremediated disease including pulmonary fibrosis [15].”
BackgroundEmphysema: looking beyond alpha-1 antitrypsin deficiency
Janssen, R., Piscaer, I., Franssen, F. M. E., & Wouters, E. F. �. (2019) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2019.1580575 · Cited by 66
Feurstein, S. K., Adegunsoye, A., Mojsilovic, D., Vij, R., DePersia, A., Rajagopal, P. S., Osman, A. E. G., Collins, R. H., Kim, R. H., Gore, S. D., et al. (2020) · Blood Advances · doi:10.1182/bloodadvances.2020001721 · Cited by 55
Combined pulmonary fibrosis and emphysema: The many aspects of a cohabitation contract
Papaioannou, A. Ι., Κostikas, Κ., Manali, E. D., Papadaki, G. F., Roussou, A., Kolilekas, L., Borie, R., Bouros, D. E., & Papiris, S. A. (2016) · Respiratory Medicine · doi:10.1016/j.rmed.2016.05.005 · Cited by 50
Precision Approaches to Chronic Obstructive Pulmonary Disease Management
Moll, M. R., & Silverman, E. K. (2023) · Annual Review of Medicine · doi:10.1146/annurev-med-060622-101239 · Cited by 54
Self-citationArish, N., Petukhov, D., & Wallach‐Dayan, S. B. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20122996 · Cited by 47
“In families, emphysema showed an autosomal dominant inheritance pattern, along with pulmonary fibrosis and other telomere syndrome features, but it manifested only in smokers [56].”
BackgroundSenescence: Pathogenic Driver in Chronic Obstructive Pulmonary Disease
Rivas, M., Gupta, G., Costanzo, L., Ahmed, H., Wyman, A. E., & Geraghty, P. M. (2022) · Medicina · doi:10.3390/medicina58060817 · Cited by 51
Liu, S., Nong, W., Ji, L., Zhuge, X., Wei, H., Luo, M., Zhou, L., Chen, S., Zhang, S., Lei, X., et al. (2023) · Experimental Gerontology · doi:10.1016/j.exger.2023.112132 · Cited by 52
Courtwright, A., Fried, S., Villalba, J. A., Moniodis, A., Guleria, I., Wood, I. G., Milford, E. L., Mallidi, H. R., Hunninghake, G. M., Raby, B. A., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0162409 · Cited by 42
Endo-phenotyping of COPD patients
Barnes, P. J. (2020) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2020.1804364 · Cited by 41
The Role of Hedgehog Signaling in Adult Lung Regeneration and Maintenance
Wang, C., Cassandras, M., & Peng, T. (2019) · Journal of Developmental Biology · doi:10.3390/jdb7030014 · Cited by 40
van Moorsel, C. H. M. (2018) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000476 · Cited by 44
Insights from human genetic studies of lung and organ fibrosis
Garcia, C. K. (2018) · Journal of Clinical Investigation · doi:10.1172/jci93556 · Cited by 40
“Notably, deleterious mutations in TERT have been found in 1% of smokers with severe emphysema (41).”
BackgroundBarnes, P. J. (2019) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-981-13-3681-2_3 · Cited by 40
Hong, X., Wang, L., Zhang, K., Liu, J., & Liu, J. (2022) · Cells · doi:10.3390/cells11050877 · Cited by 38
Whole-Genome Sequencing in Severe Chronic Obstructive Pulmonary Disease
Prokopenko, D., Sakornsakolpat, P., Fier, H. L., Qiao, D., Parker, M. M., McDonald, M., Manichaikul, A. W., Rich, S. S., Barr, R. G., Williams, C. J., et al. (2018) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2018-0088oc · Cited by 36
Self-citationWhole exome sequencing analysis in severe chronic obstructive pulmonary disease
Qiao, D., Ameli, A., Prokopenko, D., Chen, H., Kho, A. T., Parker, M. M., Morrow, J. D., Hobbs, B. D., Liu, Y., Beaty, T. H., et al. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy269 · Cited by 37
Self-citationSelman, M., Martinez, F. J., & Pardo, A. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201806-1166pp · Cited by 35
Lakota, K., Hanumanthu, V. S., Agrawal, R., Carns, M. A., Armanios, M. Y., & Varga, J. (2019) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2018-214499 · Cited by 35
Self-citationPiñeiro‐Hermida, S., Martínez, P., Bosso, G., Flores, J. M., Saraswati, S., Connor, J. R., Lemaire, R., & Blasco, M. A. (2022) · Nature Communications · doi:10.1038/s41467-022-32771-6 · Cited by 41
Role of cellular senescence in inflammatory lung diseases
Xie, C. H., Yalikun, M., Luo, Q., & Dong, J. (2023) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2023.02.001 · Cited by 33
Early-onset emphysema in a large French-Canadian family: a genetic investigation
Bossé, Y., Lamontagne, M., Gaudreault, N., Racine, C., Levesque, M.-H., Smith, B. M., Auger, D., Clemenceau, A., Paré, M., Laviolette, L., et al. (2019) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(19)30056-6 · Cited by 31
Phospholipase A2 receptor 1 promotes lung cell senescence and emphysema in obstructive lung disease
Beaulieu, D., Attwe, A., Breau, M., Lipskaia, L., Marcos, É., Born, E., Huang, J. L., Abid, S., Dérumeaux, G., Houssaini, A., et al. (2021) · European Respiratory Journal · doi:10.1183/13993003.00752-2020 · Cited by 35
Hannan, S. J., Iasella, C. J., Sutton, R. M., Popescu, I., Koshy, R., Burke, R., Chen, X., Zhang, Y., Pilewski, J. M., Hage, C. A., et al. (2023) · American Journal of Transplantation · doi:10.1016/j.ajt.2023.06.014 · Cited by 31
Self-citationAccelerated lung aging and chronic obstructive pulmonary disease
Yoon, Y.-S., Jin, M., & Sin, D. D. (2019) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2019.1580576 · Cited by 27
“disease is manifested only in smokers [30].”
Interstitial lung abnormalities are associated with decreased mean telomere length
Putman, R. K., Axelsson, G. T., Ash, S. Y., Sanders, J. L., Menon, A. A., Araki, T., Nishino, M., Yanagawa, M., Gudmundsson, E. F., Qiao, D., et al. (2022) · European Respiratory Journal · doi:10.1183/13993003.01814-2021 · Cited by 29
Self-citationRedox Regulation in Aging Lungs and Therapeutic Implications of Antioxidants in COPD
Kiyokawa, H., Hoshino, Y., Sakaguchi, K., Muro, S., & Yodoi, J. (2021) · Antioxidants · doi:10.3390/antiox10091429 · Cited by 28
“Previous studies demonstrated that telomere length is significantly shorter in patients with COPD than in healthy controls and is associated with the progression of severe emphysema after CS exposure [55,56].”
BackgroundTelomere biology and telomerase mutations in cirrhotic patients with hepatocellular carcinoma
Donaires, F. S., Scatena, N. F., Alves‐Paiva, R. M., Podlevsky, J. D., Logeswaran, D., Santana, B. A., Teixeira, A. C., Chen, J. J. ‐., Calado, R. T., & Martinelli, A. D. L. C. (2017) · PLoS ONE · doi:10.1371/journal.pone.0183287 · Cited by 27
Self-citationA systematic analysis of protein-altering exonic variants in chronic obstructive pulmonary disease
Moll, M. R., Jackson, V. E., Yu, B., Grove, M. L., London, S. J., Gharib, S. A., Bartz, T. M., Sitlani, C. M., Dupuis, J., O’Connor, G. T., et al. (2021) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00009.2021 · Cited by 24
Self-citationHedgehog Pathway and its Inhibitors in Chronic Obstructive Pulmonary Disease (COPD)Preprint
Lahmar, Z. M., Ahmed, E., Petit, A., Vachier, I., BOURDIN, A. A., & Bergougnoux, A. (2022) · SSRN Electronic Journal · doi:10.1016/j.pharmthera.2022.108295 · Cited by 23
Halu, A., Liu, S., Baek, S. H., Hobbs, B. D., Hunninghake, G. M., Cho, M. H., Silverman, E. K., & Sharma, A. (2019) · Human Molecular Genetics · doi:10.1093/hmg/ddz069 · Cited by 23
“Telomere maintenance is important in cell aging (senescence), cell division and cell survival, and telomererelated genes are highly associated with IPF (34), though they are also associated with COPD (35); (ii) COPD-up pathways that are highly prioritized with respect to IPF-down module (Table 2, lower left quadrant),…”
BackgroundSelf-citationAlpha-1 Antitrypsin Investigations Using Animal Models of Emphysema
Ni, K., Serban, K. A., Batra, C., & Petrache, I. (2016) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201510-675kv · Cited by 21
Joglekar, M. M., Bekker, N. J., Ngassie, M. L. K., Vonk, J. M., Borghuis, T., Reinders-Luinge, M., Bakker, J., Woldhuis, R. R., Pouwels, S. D., Melgert, B. N., et al. (2024) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00332.2023 · Cited by 23
What do polymorphisms tell us about the mechanisms of COPD?
Li, Y., Cho, M. H., & Zhou, X. (2017) · Clinical Science · doi:10.1042/cs20160718 · Cited by 23
Radiation Sensitivity and Radiation Necrosis in the Short Telomere Syndromes
Stanley, S. E., Rao, A. D., Gable, D. L., McGrath‐Morrow, S. A., & Armanios, M. Y. (2015) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2015.08.048 · Cited by 20
“Mutations in telomere and telomerase genes are the most common cause of familial pulmonary fibrosis cases, accounting for one-third of cases (7); they also rival alpha-1 antitrypsin deficiency as a risk factor for emphysema (8).”
BackgroundSelf-citationArimura‐Omori, M., Kiyohara, C., Yanagihara, T., Yamamoto, Y., Ogata-Suetsugu, S., Harada, E., Hamada, N., Tsuda, T., Takata, S., Shimabukuro, I., et al. (2020) · Asian Pacific Journal of Cancer Prevention · doi:10.31557/apjcp.2020.21.3.667 · Cited by 20
“Senescence may be an important factor in triggering alveolar destruction in telomere-mediated emphysema (Stanley et al., 2015).”
BackgroundGuzmán-Vargas, J., Ambrocio-Ortiz, E., Pérez-Rubio, G., Ponce-Gallegos, M. A., Hernández-Zenteno, R. D. J., Mejía, M. E., Ramírez‐Venegas, A., Buendía-Roldán, I., & Falfán‐Valencia, R. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.725144 · Cited by 23
“(39) found mutations in TERT present in female smokers with severe emphysema and a tendency to the presence of pneumothorax.”
BackgroundBreathing new life into the study of COPD with genes identified from genome-wide association studies
Werder, R. B., Zhou, X., Cho, M. H., & Wilson, A. A. (2024) · European Respiratory Review · doi:10.1183/16000617.0019-2024 · Cited by 22
“The first specific genetic cause for COPD was identified as ɑ 1 -antitrypsin deficiency, caused by a point mutation in the SERPINA1 gene [5].”
BackgroundExtrahematopoietic manifestations of the short telomere syndromes
Schratz, K. E. (2020) · Hematology · doi:10.1182/hematology.2020000170 · Cited by 26
Metadata
- Authors
- Stanley, S. E., Chen, J. J. L., Podlevsky, J. D., Alder, J. K., Hansel, N. N., Mathias, R. A., Qi, X., Rafaels, N. M., Wise, R. A., Silverman, E. K., Barnes, K. C., & Armanios, M.
- Affiliations
- Johns Hopkins University (US)
- Arizona State University (US)
- Brigham and Women's Hospital (US)
- Corresponding author
- Armanios, Mary
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2014-12-22
- Volume
- 125
- Issue
- 2
- Pages
- 563-570
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC4319417
- OpenAlex
- W2011559798
- Cited by
- 196
- References
- 42
- Citations by year
- 2026: 10 · 2025: 11 · 2024: 11 · 2023: 13 · 2022: 16 · 2021: 14 · 2020: 18 · 2019: 32 · 2018: 22 · 2017: 10 · 2016: 19 · 2015: 17 · 2014: 1
- FWCI
- 10.32
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- GlaxoSmithKline
- Commonwealth Foundation
- Johns Hopkins University
- National Institutes of Health (HL089856, HL113105)
- Pearl Therapeutics
- National Heart, Lung, and Blood Institute (HL113105, R01HL119476, R01HL089856, UC2HL102923, R01HL089897, U01HL089856, U01HL089897, R00HL113105, HL119476, HL089856, K99HL113105)
- National Human Genome Research Institute (U01HG004738)
- National Cancer Institute (R01CA160433)
- National Institute of General Medical Sciences (T32GM007309, R01GM094450)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Keywords
- telomerase mutations, telomerase reverse transcriptase, Tr, emphysema, chronic obstructive pulmonary disease, smoking, short telomeres, germline mutations, autosomal dominant inheritance, familial pulmonary fibrosis, pneumothorax, COPD susceptibility
- MeSH terms
- Adult, alpha 1-Antitrypsin, Animals, Female, Humans, Male, Middle Aged, Mutation, Pneumothorax, Pulmonary Emphysema, Pulmonary Fibrosis, Registries, Sex Characteristics, Sex Factors, Smoking, Incidence, Prevalence, Telomere, Telomerase, Chromosome Disorders, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.